OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.08
+5.19%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.40
- Revenue estimate
- $128.0K
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.38
- EPS estimate
- -$0.39
- Revenue actual
- $88.0K
- Revenue estimate
- $137.7K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +47.8%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $10
- PT range
- $10 – $11
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.39 | -$0.38 | Beat 3.06% | $88.0K |
| May 12, 2026 | -$0.40 | -$0.33 | Beat 17.50% | $110.0K |
| Mar 12, 2026 | -$0.38 | $0.26 | Beat 168.84% | $30.9M |
| Aug 12, 2025 | -$0.51 | -$0.50 | Beat 1.96% | $836.0K |
| Apr 2, 2025 | -$0.43 | -$0.43 | In line | $253.0K |
| Mar 26, 2025 | -$0.43 | -$0.37 | Beat 13.95% | $253.0K |
| Nov 13, 2023 | -$0.39 | -$0.38 | Beat 2.56% | $419.0K |
| Aug 10, 2023 | -$0.42 | -$0.35 | Beat 16.67% | $915.0K |
| May 12, 2023 | -$0.28 | -$0.40 | Miss -42.86% | $1.2M |
| Jan 24, 2023 | -$0.43 | -$0.08 | Beat 81.82% | $1.1M |
| Dec 16, 2022 | — | -$0.05 | — | $1.2M |
| Mar 31, 2022 | — | -$0.18 | — | $866.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026